Telik.org

Title

Telik, Inc.

Description

Excerpted from the website:

Telik, Inc. (Nasdaq: TELK) is a biopharmaceutical company dedicated to discovering, developing and commercializing novel small molecule drugs to treat cancer and other serious diseases. Our most advanced development candidate is TELCYTA™ (Canfosfamide), a novel cancer cell-activated chemotherapeutic. A second development candidate, TELINTRA™ (TLK199), is in clinical development in myelodysplastic syndrome, and may also have utility in the treatment of additional blood disorders. These product candidates, and the other candidates in our pipeline, were discovered using our proprietary technology, TRAP™, which enables the rapid and efficient discovery of small molecule drug candidates.
read more

Languages

English

Additional Information

Related Domains

External Links



Retrieved from "http://aboutus.com/index.php?title=Telik.org&oldid=11692306"